Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.325 enrolled

Overview

This prospective cohort and multi-site study aims to develop Taiwan version (ID Pain-T) based on the original versions of ID Pain and also DN4, and validate both ID Pain-T and DN4 applied in Taiwanese subjects at the clinical setting.

Study Type

OBSERVATIONAL

Enrollment

325

Conditions

Neuralgia Nerve Pain Neuropathic Pain

Interventions

ID-Pain DN4 QuestionnaireOTHER

This is a non-interventional questionnaire validation study

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects without headache pain over 30 days and at least 18 years old who will visit the clinic, inclusive of male and female. * Subjects who are able to complete the ID Pain-T Questionnaire. Exclusion Criteria: * Subjects who are illiterate or unable to complete questionnaire. * Subjects who are currently participating in another study or have participated in another pain study within one month of study entry. * Subjects with low back pain are unable to participate in this study; as the sciatica caused by the piriformis (exclusive of the other types of sciatic pain), lumbago, unclear identification in nerve injury (e.g. complex regional pain syndrome type I) or mixed origin (e.g. cancer pain).

Outcomes

Primary Outcomes

Determine the optimal cut-off score of ID Pain-T Questionnaire for screening of neuropathic pain

Time frame: end of study

Secondary Outcomes

Evaluate the predictive power of ID Pain-T Questionnaire for diagnosis of neuropathic pain

Time frame: end of study

Develop and evaluate validity of a short form diagnostic tool based on DN4 structure

Time frame: end of study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.